Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
409
-
Total 13F shares, excl. options
-
43.5M
-
Shares change
-
+688K
-
Total reported value, excl. options
-
$8.03B
-
Value change
-
+$131M
-
Put/Call ratio
-
1.37
-
Number of buys
-
198
-
Number of sells
-
-172
-
Price
-
$184.58
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2021
459 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2021.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.5M shares
of 44.8M outstanding shares and own 97.14% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.31M shares), VANGUARD GROUP INC (4.16M shares), RENAISSANCE TECHNOLOGIES LLC (3.03M shares), Avoro Capital Advisors LLC (3M shares), FMR LLC (2.32M shares), STATE STREET CORP (1.46M shares), Bank of New York Mellon Corp (845K shares), DEUTSCHE BANK AG\ (843K shares), FULLER & THALER ASSET MANAGEMENT, INC. (702K shares), and GEODE CAPITAL MANAGEMENT, LLC (698K shares).
This table shows the top 409 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.